Click image to enlarge
U-PLEX Combos offer popular panels of biomarkers that have been grouped together for convenient ordering. They have been tested for multiplex compatibility and are fulfilled as a kit. The U-PLEX Metabolic Hormone Combo 1 (rat) combines assays for 7 metabolic hormones (Table 1). The assays can be used for quantitative measurements in the sample types listed in the "Specifications" tab below, and offer detection limits (LLODs) in the sub- to low pg/mL range.
Analyte | LLOD - ULOD | units |
C-Peptide | 220 - 125,000 | pg/mL |
Ghrelin (active) | 13 - 7,160 | pg/mL |
GLP-1 (active) | 0.14 - 57 | pM |
Glucagon | 0.13 - 156 | pM |
Insulin | 3.0 - 5,500 | μIU/mL |
Leptin | 11 - 50,000 | pg/mL |
PYY (total) | 1.1 - 4,000 | pg/mL |
-
-
Specifications
-
Kit Contents
-
-
Documentation
-
References
Application(s)
|
|
Metabolic
|
|
Analyte(s)
|
|
C-Peptide, Ghrelin (active), GLP-1 (active), Glucagon, Insulin, Leptin, PYY (total)
|
|
Species
|
|
Rat
|
|
Instrument(s)
|
|
SECTOR Imager 2400
,
SECTOR Imager 6000
,
MESO QuickPlex SQ 120
,
MESO QuickPlex SQ 120MM
,
MESO SECTOR S 600
,
MESO SECTOR S 600MM
|
|
U-PLEX Group Compatibility
|
|
Metabolic Group 1
|
|
Plate Type
|
|
96-well
|
|
Sample Type
|
|
Cell Culture Media, EDTA Plasma, P800 Plasma, Serum
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
Storage Condition
|
|
Multi-Component
|
|
Schedule B Code
|
|
3822.19.0000
|
|
Product Description
|
Storage
|
Quantity per Kit
|
U-PLEX Linker Set, 7-Assay (300 µL)
|
2-8 °C
|
1 each (1 vial)
|
|
|
2-8 °C
|
1 each (1 plate size)
|
|
|
2-8 °C
|
1 each (1 plate size)
|
|
|
2-8 °C
|
1 each (1 plate size)
|
|
|
2-8 °C
|
1 each (1 plate size)
|
|
|
2-8 °C
|
1 each (1 plate size)
|
|
|
2-8 °C
|
1 each (1 plate size)
|
|
|
2-8 °C
|
1 each (1 plate size)
|
|
|
2-8 °C
|
1 vial (1 vial)
|
|
|
2-8 °C
|
1 vial (1 vial)
|
|
|
2-8 °C
|
1 vial (1 vial)
|
|
|
2-8 °C
|
1 vial (1 vial)
|
|
U-PLEX 7-Assay, 96-Well SECTOR Plate
|
2-8 °C
|
1 each (1 plate)
|
|
U-PLEX Stop Solution
|
2-8 °C
|
1 bottle (40 mL)
|
|
|
≤-10 °C
|
1 bottle (10 mL)
|
|
|
≤-10 °C
|
1 bottle (10 mL)
|
|
|
RT
|
1 bottle (18 mL)
|
|
Aprotinin
|
2-8 °C
|
1 vial (50 μL)
|
|
|
≤-10 °C
|
1 vial (0.2 mL)
|
|
Product Description
|
Storage
|
Quantity per Kit
|
U-PLEX Linker Set, 7-Assay (1.8 mL)
|
2-8 °C
|
1 each (1 vial)
|
|
|
2-8 °C
|
1 each (5 plate size)
|
|
|
2-8 °C
|
1 each (5 plate size)
|
|
|
2-8 °C
|
1 each (5 plate size)
|
|
|
2-8 °C
|
1 each (5 plate size)
|
|
|
2-8 °C
|
1 each (5 plate size)
|
|
|
2-8 °C
|
1 each (5 plate size)
|
|
|
2-8 °C
|
1 each (5 plate size)
|
|
|
2-8 °C
|
5 vial (1 vial)
|
|
|
2-8 °C
|
5 vial (1 vial)
|
|
|
2-8 °C
|
5 vial (1 vial)
|
|
|
2-8 °C
|
5 vial (1 vial)
|
|
U-PLEX 7-Assay, 96-Well SECTOR Plate
|
2-8 °C
|
5 each (1 plate)
|
|
U-PLEX Stop Solution
|
2-8 °C
|
1 bottle (40 mL)
|
|
|
≤-10 °C
|
1 bottle (50 mL)
|
|
|
≤-10 °C
|
1 bottle (50 mL)
|
|
|
RT
|
1 bottle (90 mL)
|
|
Aprotinin
|
2-8 °C
|
1 vial (250 μL)
|
|
|
≤-10 °C
|
1 vial (1 mL)
|
|
Product Description
|
Storage
|
Quantity per Kit
|
U-PLEX Linker Set, 7-Assay (1.8 mL)
|
2-8 °C
|
5 each (1 vial)
|
|
|
2-8 °C
|
5 each (5 plate size)
|
|
|
2-8 °C
|
5 each (5 plate size)
|
|
|
2-8 °C
|
5 each (5 plate size)
|
|
|
2-8 °C
|
5 each (5 plate size)
|
|
|
2-8 °C
|
5 each (5 plate size)
|
|
|
2-8 °C
|
5 each (5 plate size)
|
|
|
2-8 °C
|
5 each (5 plate size)
|
|
|
2-8 °C
|
25 vial (1 vial)
|
|
|
2-8 °C
|
25 vial (1 vial)
|
|
|
2-8 °C
|
25 vial (1 vial)
|
|
|
2-8 °C
|
25 vial (1 vial)
|
|
U-PLEX 7-Assay, 96-Well SECTOR Plate
|
2-8 °C
|
25 each (1 plate)
|
|
U-PLEX Stop Solution
|
2-8 °C
|
5 bottle (40 mL)
|
|
|
≤-10 °C
|
5 bottle (50 mL)
|
|
|
≤-10 °C
|
5 bottle (50 mL)
|
|
|
RT
|
5 bottle (90 mL)
|
|
Aprotinin
|
2-8 °C
|
5 vial (250 μL)
|
|
|
≤-10 °C
|
5 vial (1 mL)
|
|
Product Inserts
|
|
|
Datasheets
|
|
|
Product Highlights
|
|
|
SDS
|
|
|
Title
|
Journal
|
Year
|
|
Islet Autoantibody Standardization Program: interlaboratory comparison of insulin autoantibody assay performance in 2018 and 2020 workshops
|
|
|
|
Leptin levels are associated with multiple sclerosis risk
|
|
|
|
Genetic Deletion and Pharmacological Inhibition of Phosphodiesterase 10A Protects Mice From Diet-Induced Obesity and Insulin Resistance.
|
|
|
|
A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt study.
|
|
|
|
Beneficial effects of parenteral GLP-1 delivery by cell therapy in insulin-deficient streptozotocin diabetic mice.
|
|
|
|
View All
|
Order Details
Catalog No
Size
Price in USD
Qty
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters